Molecular hydrogen: current knowledge on mechanism in alleviating free radical damage and diseases

Acta Biochim Biophys Sin (Shanghai). 2019 Dec 13;51(12):1189-1197. doi: 10.1093/abbs/gmz121.

Abstract

Ever since molecular hydrogen was first reported as a hydroxyl radical scavenger in 2007, the beneficial effect of hydrogen was documented in more than 170 disease models and human diseases including ischemia/reperfusion injury, metabolic syndrome, inflammation, and cancer. All these pathological damages are concomitant with overproduction of reactive oxygen species (ROS) where molecular hydrogen has been widely demonstrated as a selective antioxidant. Although it is difficult to construe the molecular mechanism of hydrogen's biomedical effect, an increasing number of studies have been helping us draw the picture clearer with days passing by. In this review, we summarized the current knowledge on systemic and cellular modulation by hydrogen treatment. We discussed the antioxidative, anti-inflammatory, and anti-apoptosis effects of hydrogen, as well as its protection on mitochondria and the endoplasmic reticulum, regulation of intracellular signaling pathways, and balancing of the immune cell subtypes. We hope that this review will provide organized information that prompts further investigation for in-depth studies of hydrogen effect.

Keywords: anti-apoptosis; anti-inflammation; antioxidant; molecular hydrogen; molecular mechanism.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents / pharmacology
  • Cells, Cultured
  • Free Radical Scavengers / pharmacology*
  • Humans
  • Hydrogen / pharmacology*
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Oxidative Stress / drug effects*
  • Reactive Oxygen Species / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Free Radical Scavengers
  • Reactive Oxygen Species
  • Hydrogen